Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

AOCS Group, CZECANCA Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium, HEBON Investigators, GEMO Study Collaborators

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2'. Together they form a unique fingerprint.

Medicine & Life Sciences